Other defining parameters such as molecular data, i.e., the identification of the PML::RARA transcript, usually fall into a 3-day turnaround window, hence the need for MFC analysis to confirm an APL diagnosis sooner. The gene discussed is RARA; the disease is acute promyelocytic leukemia.